Compounds > capecitabine
Page last updated: 2024-08-24

capecitabine and Graft vs Host Disease

capecitabine has been researched along with Graft vs Host Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Cox, BK; Guindi, M; Hutchings, DA; Larson, BK; Ojukwu, K; Waters, KM1
Konda, S; O'Bryan, KW; Patel, VA; Ratner, D1

Other Studies

2 other study(ies) available for capecitabine and Graft vs Host Disease

ArticleYear
Capecitabine-induced Gastrointestinal Injury Shows a Graft-Versus-Host Disease (GVHD)-like Pattern.
    The American journal of surgical pathology, 2023, 10-01, Volume: 47, Issue:10

    Topics: Adult; Biopsy; Capecitabine; Colon; Gastrointestinal Diseases; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Retrospective Studies

2023
Fibrohistiocytic tumors in a lung transplant patient taking oral capecitabine for nonmelanoma skin cancer chemoprevention.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2014, Volume: 40, Issue:7

    Topics: Acitretin; Aged; Antimetabolites, Antineoplastic; Capecitabine; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Deoxycytidine; Fatal Outcome; Fluorouracil; Graft vs Host Disease; Head and Neck Neoplasms; Histiocytoma, Malignant Fibrous; Humans; Keratolytic Agents; Lung Transplantation; Male; Skin Neoplasms

2014